 | • レポートコード：D0804-16192 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、治療用核薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。治療用核薬の種類別市場規模（ラジウム-223、ルテチウム-177、ヨウ素-131、その他）、用途別市場規模（甲状腺、骨転移、リンパ腫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Lantheus、Dongcheng、Novartis、Jubilant DraxImage、China Isotope & Radiation、Progenics Pharmaceuticals、Curium Pharmaceuticals、Q BioMed、Spectrum Pharmaceuticals、International Isotopes ・地域別グローバル市場分析 2015年-2020年 ・治療用核薬の北米市場（アメリカ、カナダ、メキシコ） ・治療用核薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・治療用核薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・治療用核薬の南米市場（ブラジル、アルゼンチン） ・治療用核薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ラジウム-223、ルテチウム-177、ヨウ素-131、その他 ・用途別分析：甲状腺、骨転移、リンパ腫、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Nuclear Drug for Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nuclear Drug for Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nuclear Drug for Therapeutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nuclear Drug for Therapeutic market has been segmented into:
Radium-223
Lutetium-177
Iodine-131
Other
By Application, Nuclear Drug for Therapeutic has been segmented into:
Thyroid
Bone Metastasis
Lymphoma
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Drug for Therapeutic market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Drug for Therapeutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Drug for Therapeutic market.
The report offers in-depth assessment of the growth and other aspects of the Nuclear Drug for Therapeutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Nuclear Drug for Therapeutic Market Share Analysis
Nuclear Drug for Therapeutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Drug for Therapeutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Drug for Therapeutic sales, revenue and market share for each player covered in this report.
The major players covered in Nuclear Drug for Therapeutic are:
Bayer
Lantheus
Dongcheng
Novartis
Jubilant DraxImage
China Isotope & Radiation
Progenics Pharmaceuticals
Curium Pharmaceuticals
Q BioMed
Spectrum Pharmaceuticals
International Isotopes
Table of Contents
1 Nuclear Drug for Therapeutic Market Overview
1.1 Product Overview and Scope of Nuclear Drug for Therapeutic
1.2 Classification of Nuclear Drug for Therapeutic by Type
1.2.1 Global Nuclear Drug for Therapeutic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Type in 2019
1.2.3 Radium-223
1.2.4 Lutetium-177
1.2.5 Iodine-131
1.2.6 Other
1.3 Global Nuclear Drug for Therapeutic Market by Application
1.3.1 Overview: Global Nuclear Drug for Therapeutic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Nuclear Drug for Therapeutic Market by Regions
1.4.1 Global Nuclear Drug for Therapeutic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nuclear Drug for Therapeutic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nuclear Drug for Therapeutic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nuclear Drug for Therapeutic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nuclear Drug for Therapeutic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nuclear Drug for Therapeutic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nuclear Drug for Therapeutic Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lantheus
2.2.1 Lantheus Details
2.2.2 Lantheus Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lantheus SWOT Analysis
2.2.4 Lantheus Product and Services
2.2.5 Lantheus Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Dongcheng
2.3.1 Dongcheng Details
2.3.2 Dongcheng Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Dongcheng SWOT Analysis
2.3.4 Dongcheng Product and Services
2.3.5 Dongcheng Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Jubilant DraxImage
2.5.1 Jubilant DraxImage Details
2.5.2 Jubilant DraxImage Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Jubilant DraxImage SWOT Analysis
2.5.4 Jubilant DraxImage Product and Services
2.5.5 Jubilant DraxImage Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.6 China Isotope & Radiation
2.6.1 China Isotope & Radiation Details
2.6.2 China Isotope & Radiation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 China Isotope & Radiation SWOT Analysis
2.6.4 China Isotope & Radiation Product and Services
2.6.5 China Isotope & Radiation Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Progenics Pharmaceuticals
2.7.1 Progenics Pharmaceuticals Details
2.7.2 Progenics Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Progenics Pharmaceuticals SWOT Analysis
2.7.4 Progenics Pharmaceuticals Product and Services
2.7.5 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Curium Pharmaceuticals
2.8.1 Curium Pharmaceuticals Details
2.8.2 Curium Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Curium Pharmaceuticals SWOT Analysis
2.8.4 Curium Pharmaceuticals Product and Services
2.8.5 Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Q BioMed
2.9.1 Q BioMed Details
2.9.2 Q BioMed Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Q BioMed SWOT Analysis
2.9.4 Q BioMed Product and Services
2.9.5 Q BioMed Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.10 Spectrum Pharmaceuticals
2.10.1 Spectrum Pharmaceuticals Details
2.10.2 Spectrum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Spectrum Pharmaceuticals SWOT Analysis
2.10.4 Spectrum Pharmaceuticals Product and Services
2.10.5 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.11 International Isotopes
2.11.1 International Isotopes Details
2.11.2 International Isotopes Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 International Isotopes SWOT Analysis
2.11.4 International Isotopes Product and Services
2.11.5 International Isotopes Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nuclear Drug for Therapeutic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nuclear Drug for Therapeutic Players Market Share
3.2.2 Top 10 Nuclear Drug for Therapeutic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nuclear Drug for Therapeutic Revenue and Market Share by Regions
4.2 North America Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
4.3 Europe Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
4.5 South America Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
5 North America Nuclear Drug for Therapeutic Revenue by Countries
5.1 North America Nuclear Drug for Therapeutic Revenue by Countries (2015-2020)
5.2 USA Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
5.3 Canada Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
5.4 Mexico Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
6 Europe Nuclear Drug for Therapeutic Revenue by Countries
6.1 Europe Nuclear Drug for Therapeutic Revenue by Countries (2015-2020)
6.2 Germany Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
6.3 UK Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
6.4 France Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
6.5 Russia Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
6.6 Italy Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nuclear Drug for Therapeutic Revenue by Countries
7.1 Asia-Pacific Nuclear Drug for Therapeutic Revenue by Countries (2015-2020)
7.2 China Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
7.3 Japan Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
7.4 Korea Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
7.5 India Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
8 South America Nuclear Drug for Therapeutic Revenue by Countries
8.1 South America Nuclear Drug for Therapeutic Revenue by Countries (2015-2020)
8.2 Brazil Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
8.3 Argentina Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nuclear Drug for Therapeutic by Countries
9.1 Middle East & Africa Nuclear Drug for Therapeutic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
9.3 UAE Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
9.4 Egypt Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
9.5 South Africa Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nuclear Drug for Therapeutic Revenue and Market Share by Type (2015-2020)
10.2 Global Nuclear Drug for Therapeutic Market Forecast by Type (2019-2024)
10.3 Radium-223 Revenue Growth Rate (2015-2025)
10.4 Lutetium-177 Revenue Growth Rate (2015-2025)
10.5 Iodine-131 Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Nuclear Drug for Therapeutic Market Segment by Application
11.1 Global Nuclear Drug for Therapeutic Revenue Market Share by Application (2015-2020)
11.2 Nuclear Drug for Therapeutic Market Forecast by Application (2019-2024)
11.3 Thyroid Revenue Growth (2015-2020)
11.4 Bone Metastasis Revenue Growth (2015-2020)
11.5 Lymphoma Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Nuclear Drug for Therapeutic Market Size Forecast (2021-2025)
12.1 Global Nuclear Drug for Therapeutic Market Size Forecast (2021-2025)
12.2 Global Nuclear Drug for Therapeutic Market Forecast by Regions (2021-2025)
12.3 North America Nuclear Drug for Therapeutic Revenue Market Forecast (2021-2025)
12.4 Europe Nuclear Drug for Therapeutic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nuclear Drug for Therapeutic Revenue Market Forecast (2021-2025)
12.6 South America Nuclear Drug for Therapeutic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nuclear Drug for Therapeutic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Nuclear Drug for Therapeutic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nuclear Drug for Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nuclear Drug for Therapeutic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nuclear Drug for Therapeutic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bayer Corporate Information, Location and Competitors
Table 6. Bayer Nuclear Drug for Therapeutic Major Business
Table 7. Bayer Nuclear Drug for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 8. Bayer SWOT Analysis
Table 9. Bayer Nuclear Drug for Therapeutic Product and Solutions
Table 10. Bayer Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Lantheus Corporate Information, Location and Competitors
Table 12. Lantheus Nuclear Drug for Therapeutic Major Business
Table 13. Lantheus Nuclear Drug for Therapeutic Total Revenue (USD Million) (2018-2019)
Table 14. Lantheus SWOT Analysis
Table 15. Lantheus Nuclear Drug for Therapeutic Product and Solutions
Table 16. Lantheus Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Dongcheng Corporate Information, Location and Competitors
Table 18. Dongcheng Nuclear Drug for Therapeutic Major Business
Table 19. Dongcheng Nuclear Drug for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 20. Dongcheng SWOT Analysis
Table 21. Dongcheng Nuclear Drug for Therapeutic Product and Solutions
Table 22. Dongcheng Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Nuclear Drug for Therapeutic Major Business
Table 25. Novartis Nuclear Drug for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Nuclear Drug for Therapeutic Product and Solutions
Table 28. Novartis Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Jubilant DraxImage Corporate Information, Location and Competitors
Table 30. Jubilant DraxImage Nuclear Drug for Therapeutic Major Business
Table 31. Jubilant DraxImage Nuclear Drug for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 32. Jubilant DraxImage SWOT Analysis
Table 33. Jubilant DraxImage Nuclear Drug for Therapeutic Product and Solutions
Table 34. Jubilant DraxImage Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. China Isotope & Radiation Corporate Information, Location and Competitors
Table 36. China Isotope & Radiation Nuclear Drug for Therapeutic Major Business
Table 37. China Isotope & Radiation Nuclear Drug for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 38. China Isotope & Radiation SWOT Analysis
Table 39. China Isotope & Radiation Nuclear Drug for Therapeutic Product and Solutions
Table 40. China Isotope & Radiation Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Progenics Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Major Business
Table 43. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 44. Progenics Pharmaceuticals SWOT Analysis
Table 45. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product and Solutions
Table 46. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Curium Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Curium Pharmaceuticals Nuclear Drug for Therapeutic Major Business
Table 49. Curium Pharmaceuticals Nuclear Drug for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 50. Curium Pharmaceuticals SWOT Analysis
Table 51. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product and Solutions
Table 52. Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Q BioMed Corporate Information, Location and Competitors
Table 54. Q BioMed Nuclear Drug for Therapeutic Major Business
Table 55. Q BioMed Nuclear Drug for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 56. Q BioMed SWOT Analysis
Table 57. Q BioMed Nuclear Drug for Therapeutic Product and Solutions
Table 58. Q BioMed Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Spectrum Pharmaceuticals Corporate Information, Location and Competitors
Table 60. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Major Business
Table 61. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 62. Spectrum Pharmaceuticals SWOT Analysis
Table 63. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product and Solutions
Table 64. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. International Isotopes Corporate Information, Location and Competitors
Table 66. International Isotopes Nuclear Drug for Therapeutic Major Business
Table 67. International Isotopes Nuclear Drug for Therapeutic Total Revenue (USD Million) (2017-2018)
Table 68. International Isotopes SWOT Analysis
Table 69. International Isotopes Nuclear Drug for Therapeutic Product and Solutions
Table 70. International Isotopes Nuclear Drug for Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Nuclear Drug for Therapeutic Revenue (Million USD) by Players (2015-2020)
Table 72. Global Nuclear Drug for Therapeutic Revenue Share by Players (2015-2020)
Table 73. Global Nuclear Drug for Therapeutic Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Nuclear Drug for Therapeutic Revenue Market Share by Regions (2015-2020)
Table 75. North America Nuclear Drug for Therapeutic Revenue by Countries (2015-2020)
Table 76. North America Nuclear Drug for Therapeutic Revenue Market Share by Countries (2015-2020)
Table 77. Europe Nuclear Drug for Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Nuclear Drug for Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Nuclear Drug for Therapeutic Revenue by Countries (2015-2020)
Table 80. South America Nuclear Drug for Therapeutic Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Nuclear Drug for Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Nuclear Drug for Therapeutic Revenue Market Share by Countries (2015-2020)
Table 83. Global Nuclear Drug for Therapeutic Revenue (Million USD) by Type (2015-2020)
Table 84. Global Nuclear Drug for Therapeutic Revenue Share by Type (2015-2020)
Table 85. Global Nuclear Drug for Therapeutic Revenue Forecast by Type (2021-2025)
Table 86. Global Nuclear Drug for Therapeutic Revenue by Application (2015-2020)
Table 87. Global Nuclear Drug for Therapeutic Revenue Share by Application (2015-2020)
Table 88. Global Nuclear Drug for Therapeutic Revenue Forecast by Application (2021-2025)
Table 89. Global Nuclear Drug for Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nuclear Drug for Therapeutic Picture
Figure 2. Global Nuclear Drug for Therapeutic Revenue Market Share by Type in 2019
Figure 3. Radium-223 Picture
Figure 4. Lutetium-177 Picture
Figure 5. Iodine-131 Picture
Figure 6. Other Picture
Figure 7. Nuclear Drug for Therapeutic Revenue Market Share by Application in 2019
Figure 8. Thyroid Picture
Figure 9. Bone Metastasis Picture
Figure 10. Lymphoma Picture
Figure 11. Other Picture
Figure 12. Global Nuclear Drug for Therapeutic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Nuclear Drug for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Nuclear Drug for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Nuclear Drug for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Nuclear Drug for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Nuclear Drug for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Nuclear Drug for Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Nuclear Drug for Therapeutic Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Nuclear Drug for Therapeutic Revenue Market Share in 2019
Figure 21. Global Top 10 Players Nuclear Drug for Therapeutic Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Nuclear Drug for Therapeutic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Nuclear Drug for Therapeutic Revenue Market Share by Regions (2015-2020)
Figure 25. Global Nuclear Drug for Therapeutic Revenue Market Share by Regions in 2018
Figure 26. North America Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 27. Europe Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 29. South America Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 31. North America Nuclear Drug for Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 32. North America Nuclear Drug for Therapeutic Revenue Market Share by Countries in 2019
Figure 33. USA Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 34. Canada Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 36. Europe Nuclear Drug for Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Nuclear Drug for Therapeutic Revenue Market Share by Countries in 2019
Figure 38. Germany Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 39. UK Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 40. France Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 41. Russia Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 42. Italy Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Nuclear Drug for Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Nuclear Drug for Therapeutic Revenue Market Share by Countries in 2019
Figure 45. China Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 46. Japan Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 47. Korea Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 48. India Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 50. South America Nuclear Drug for Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 51. South America Nuclear Drug for Therapeutic Revenue Market Share by Countries in 2019
Figure 52. Brazil Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Nuclear Drug for Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Nuclear Drug for Therapeutic Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 57. UAE Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Nuclear Drug for Therapeutic Revenue and Growth Rate (2015-2020)
Figure 60. Global Nuclear Drug for Therapeutic Revenue Share by Type (2015-2020)
Figure 61. Global Nuclear Drug for Therapeutic Revenue Share by Type in 2019
Figure 62. Global Nuclear Drug for Therapeutic Market Share Forecast by Type (2021-2025)
Figure 63. Global Radium-223 Revenue Growth Rate (2015-2020)
Figure 64. Global Lutetium-177 Revenue Growth Rate (2015-2020)
Figure 65. Global Iodine-131 Revenue Growth Rate (2015-2020)
Figure 66. Global Other Revenue Growth Rate (2015-2020)
Figure 67. Global Nuclear Drug for Therapeutic Revenue Share by Application (2015-2020)
Figure 68. Global Nuclear Drug for Therapeutic Revenue Share by Application in 2019
Figure 69. Global Nuclear Drug for Therapeutic Market Share Forecast by Application (2021-2025)
Figure 70. Global Thyroid Revenue Growth Rate (2015-2020)
Figure 71. Global Bone Metastasis Revenue Growth Rate (2015-2020)
Figure 72. Global Lymphoma Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global Nuclear Drug for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Nuclear Drug for Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Nuclear Drug for Therapeutic Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Nuclear Drug for Therapeutic Revenue Market Forecast (2021-2025)
Figure 78. Europe Nuclear Drug for Therapeutic Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Nuclear Drug for Therapeutic Revenue Market Forecast (2021-2025)
Figure 80. South America Nuclear Drug for Therapeutic Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Nuclear Drug for Therapeutic Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
抗凝固治療薬モニタリングアッセイキットの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anticoagulant Therapeutic Drug Monitoring Assay Kit market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…- 治療用放射性医薬品の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Radiopharmaceuticals for Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Radiopha…
- ウジ治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Maggot Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Maggot Therapeutic market …
- 治療用ワクチンの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Therapeutic Vaccines mar…
- 治療用カテーテルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Therapeutic Catheters market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…